In this retrospective study, a total of 47 MET fusions with an intact kinase domain (KD) were detected in 44 lung cancer patients (Fig. 1A and Table S1, 2) whose baseline and/or post-treatment samples underwent capture-based hybrid targeted next-generation sequencing (NGS) between April 2016 and December 2021. The gene discussed is MET; the disease is lung cancer.